Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Open accessThe DOI matches its Crossref record.
Abstract
Cell contact with the extracellular matrix component hyaluronic acid (HA) plays an important role in many developmental, physiological, and pathological processes, although the regulation of this contact is poorly understood. CD44 proteins carry an amino acid motif that mediates affinity to HA. Artificial clustering of the smallest 85-kD isoform of CD44 (CD44s) has previously been shown to promote binding of the protein to soluble HA (Lesley, J., R. Hyman, and P.W. Kincade. 1993. Adv. Immunol. 54:271-335; Persche, A., J. Lesley, N. English, I. Trowbridge, and R. Hyman. 1995. Eur. J. Immunol. 25:495-501). Here we show that in rat pancreatic carcinoma cells, splice variants of CD44 (CD44v), but not CD44s, form molecular aggregates in the plasma membrane. We demonstrate that reduction-sensitive dimerization of CD44v occurs, and also that larger aggregations of the protein can be stabilized by chemical cross-linking. Different CD44v proteins present on the same cell exclusively form homoaggregates. Molecular clustering does not require an intact cytoplasmic domain of the protein. The ability of cells to bind to soluble HA is upregulated more than one magnitude by the ectopic expression of CD44v4-v7, but only when the CD44v4-v7 protein forms intermolecular aggregates. Tunicamycin treatment inhibits HA binding by CD44v and at the same time destroys oligomerization. We propose that the regulation of clustering of CD44, mediated by factors including the presence of variant exons and glycosylation, allows cells in turn to regulate their HA binding properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Syndecans: multifunctional cell-surface co-receptors
CAREY, D. J. (1997) · Biochemical Journal · doi:10.1042/bj3270001 · Cited by 691
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Toole, B. P. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0244 · Cited by 570
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H., & Herrlich, P. (2001) · Genes & Development · doi:10.1101/gad.189601 · Cited by 536
Self-citationCD44 is required for two consecutive steps in HGF/c-Met signaling
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
Self-citationHyaluronan, a Crucial Regulator of Inflammation
Petrey, A. C., & de la Motte, C. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00101 · Cited by 514
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
Evanko, S. P., Angello, J. C., & Wight, T. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1004 · Cited by 487
Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium
Prevo, R., Banerji, S., Ferguson, D. J. P., Clasper, S., & Jackson, D. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011004200 · Cited by 477
CD44, a therapeutic target for metastasising tumours
Orian-Rousseau, V. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.024 · Cited by 474
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Analysis of Cd44-Containing Lipid Rafts
Oliferenko, S., Paiha, K., Harder, T., Gerke, V., Schwärzler, C., Schwarz, H., Beug, H., Günthert, U., & Huber, L. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.843 · Cited by 405
The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
Yang, C., Cao, M., Liu, H., He, Y., Xu, J., Du, Y., Liu, Y., Wang, W., Cui, L., Hu, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349209 · Cited by 309
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
Naor, D., Wallach-Dayan, S. B., Zahalka, M. A., & Sionov, R. V. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.015 · Cited by 309
Bacac, M., & Stamenkovic, I. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151523 · Cited by 286
Okamoto, I., Kawano, Y., Tsuiki, H., Sasaki, J.-I., Nakao, M., Matsumoto, M., Suga, M., Ando, M., Nakajima, M., & Saya, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202447 · Cited by 257
Yu, Q., Toole, B. P., & Stamenkovic, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1985 · Cited by 250
“It has been shown that cell surface CD44 can form aggregates as a result of binding to HA, which may be important for subsequent internalization and processing (32).”
BackgroundHyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism
Tammi, R., Rilla, K., Pienimäki, J.-P., MacCallum, D. K., Hogg, M., Luukkonen, M., Hascall, V. C., & Tammi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103481200 · Cited by 240
Development of a Peptide Inhibitor of Hyaluronan-Mediated Leukocyte Trafficking
Mummert, M. E., Mohamadzadeh, M., Mummert, D. I., Mizumoto, N., & Takashima, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.769 · Cited by 166
SHAP Potentiates the CD44-mediated Leukocyte Adhesion to the Hyaluronan Substratum
Zhuo, L., Kanamori, A., Kannagi, R., Itano, N., Wu, J., Hamaguchi, M., Ishiguro, N., & Kimata, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506703200 · Cited by 150
Metadata
- Authors
- Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., & Ponta, H.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1996-11-15
- Volume
- 135
- Issue
- 4
- Pages
- 1139-1150
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2119139128
- Cited by
- 156
- References
- 0
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.